BIOCHEMICAL, PHYSIOLOGICAL AND MEDICAL ASPECTS OF UBIQUINONE FUNCTION

被引:961
作者
ERNSTER, L [1 ]
DALLNER, G [1 ]
机构
[1] KAROLINSKA INST, NOVUM, CLIN RES CTR, S-14186 HUDDINGE, SWEDEN
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 1995年 / 1271卷 / 01期
关键词
UBIQUINONE; ANTIOXIDANT; PROOXIDANT; FREE RADICAL;
D O I
10.1016/0925-4439(95)00028-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This presentation is a brief review of current knowledge concerning some biochemical, physiological and medical aspects of the function of ubiquinone (coenzyme Q) in mammalian organisms. In addition to its well-established function as a component of the mitochondrial respiratory chain, ubiquinone has in recent years acquired increasing attention with regard to its function in the reduced form (ubiquinol) as an antioxidant. Ubiquinone, partly in the reduced form, occurs in all cellular membranes as well as in blood serum and in serum lipoproteins. Ubiquinol efficiently protects membrane phospholipids and serum low-density lipoprotein from lipid peroxidation, and, as recent data indicate, also mitochondrial membrane proteins and DNA from free-radical induced oxidative damage. These effects of ubiquinol are independent of those of exogenous antioxidants, such as vitamin E, although ubiquinol can also potentiate the effect of vitamin E by regenerating it from its oxidized form. Tissue ubiquinone levels are regulated through the mevalonate pathway, increasing upon various forms of oxidative stress, and decreasing during aging. Drugs inhibiting inhibiting cholesterol biosynthesis via the mevalonate pathway may inhibit or stimulate ubiquinone biosynthesis, depending on their site of action. Administration of ubiquinone as a dietary supplement seems to lead primarily to increased serum levels, which may account for most of the reported beneficial effects of ubiquinone intake in various instances of experimental and clinical medicine.
引用
收藏
页码:195 / 204
页数:10
相关论文
共 100 条
[71]   STOPPED-FLOW KINETIC-STUDY OF THE REGENERATION REACTION OF TOCOPHEROXYL RADICAL BY REDUCED UBIQUINONE-10 IN SOLUTION [J].
MUKAI, K ;
KIKUCHI, S ;
URANO, S .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1035 (01) :77-82
[72]   ANTIOXIDANTS IN RELATION TO LIPID-PEROXIDATION [J].
NIKI, E .
CHEMISTRY AND PHYSICS OF LIPIDS, 1987, 44 (2-4) :227-253
[73]   STUDIES WITH UBIQUINONE-DEPLETED SUBMITOCHONDRIAL PARTICLES - QUANTITATIVE INCORPORATION OF SMALL AMOUNTS OF UBIQUINONE AND ITS EFFECTS ON NADH AND SUCCINATE OXIDASE ACTIVITIES [J].
NORLING, B ;
GLAZEK, E ;
NELSON, BD ;
ERNSTER, L .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1974, 47 (03) :475-482
[74]  
OLSSON JM, 1991, CANCER RES, V51, P3774
[75]   LIPID-PEROXIDATION PRODUCTS MEDIATE THE FORMATION OF 8-HYDROXYDEOXYGUANOSINE IN DNA [J].
PARK, JW ;
FLOYD, RA .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 12 (04) :245-250
[76]   UBIQUINONE (COENZYME Q) AND REGULATION OF BASAL METABOLIC RATE BY THYROID HORMONES [J].
PEDERSEN, S ;
TATA, JR ;
ERNSTER, L .
BIOCHIMICA ET BIOPHYSICA ACTA, 1963, 69 (02) :407-&
[77]  
Quinn P. J. K., 1985, COENZYME Q, P107
[78]  
RAMASARMA T, 1985, COENZYME Q BIOCH BIO, P67
[79]  
REAHAL S, 1992, DRUG METAB DISPOS, V20, P423
[80]  
SIES H, 1993, EFFICACY VITAMIN E H